The platinum drugs most effective in treating ovarian cancer are in limited supply due to the drug shortage; the government proposes a plan to prevent hospitals from redistributing Medicaid money; physicians ask for help in treating the high number of children with mental illness coming to the emergency department.
Patients with ovarian cancer are among the groups most affected by the drug shortages as the most effective platinum drugs carboplatin and cisplatin are in limited supply, according to Stat News. Both drugs have been hard to keep stocked for months in most cancer centers, as 93% reported carboplatin shortages and 70% reported cisplatin shortages. Although there are alternatives to platinum drugs in ovarian cancer treatment, none work as well as carboplatin in combination with the chemotherapy drug paclitaxel, especially when the treatment could be curative. Patients have described a significant physical and emotional toll from needing to use less-than-optimal alternatives.
The Biden administration may punish hospitals violating federal law by making private arrangements to reimburse themselves for taxes that help fund coverage for low-income patients, according to KFF Health News. Federal regulators explained that hospitals disregarded the proposed enforcement plan released May 3 by CMS that designated the money for facilities treating low-income patients, instead redirecting it to ones that provide little to no Medicaid-covered services. The government’s most recent proposal against this secret but widespread practice requires states to monitor the use of Medicaid money in hospitals, nursing homes, and other health care providers to make sure it is not redistributed. However, some Medicaid experts predict this plan could fail or face immediate challenges in court if adopted.
Emergency medicine providers and pediatricians pleaded for additional support and resources due to the number of children and teenagers with mental health concerns presenting to emergency departments nationwide, according to NBC News. The article covered a joint policy statement from the American College of Emergency Physicians, the American Academy of Pediatrics, and the Emergency Nurses Association released Wednesday. In the statement, the groups call for increased access to mental health services in local communities to prevent the need for emergency care. Although emergency physicians can address mental health issues at the surface level, the groups write, they typically do not have the resources to do so over long periods.
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
May 1st 2024Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among those with non-BRCA-like tumors, a study found.
Read More
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More
Most Patients With Mucinous Ovarian Cancer Don't Need Perioperative GI Endoscopy
April 12th 2024A new study suggests routine gastrointestinal (GI) endoscopy is not needed for most patients with mucinous ovarian cancer in the perioperative setting due to a lack of statistically significant overall survival benefits.
Read More
Model Including Diffusion-Weighted MRI More Accurately Predicts Ovarian Cancer Resectability
April 4th 2024A recent study suggests a modified model incorporating diffusion-weighted MRI can more accurately predict ovarian cancer primary debulking surgery outcomes compared with the standard, widely used Memorial Sloan Kettering Cancer Center risk model.
Read More